Lacomasid 50 Tablet contains Lacosamide 500mg, a high-strength antiepileptic agent for managing partial-onset seizures and epilepsy. It works by modulating hyperexcitable neuronal membranes and controlling repetitive neuronal firing, effectively reducing seizure episodes.
Belonging to the CNS and neurology segment, this 500mg strength is ideal for maintenance therapy, dose escalation, or patients requiring higher seizure control. Its efficacy and tolerability make it a preferred choice for neurologists managing complex epilepsy cases.
The formulation ensures consistent seizure management, providing reliability for both hospital and outpatient settings. It sees strong prescription demand in neurology clinics, hospital pharmacies, and retail markets.
For PCD pharma franchise partners, wholesalers, exporters, and third-party manufacturers, Lacobent 500 Tablet offers a profitable B2B opportunity in the antiepileptic segment, with stable market demand and long-term growth potential across India.